Manufacture of Asymmetric Hydrogenation Catalysts - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Manufacture of Asymmetric Hydrogenation Catalysts
Single-enantiomer drugs represent an increasingly large share of new chemical entities, leading to approaches in asymmetric synthesis.

Pharmaceutical Technology

14. M.J. Burk, "C2-Symmetric Bis(phospholanes) and their Use in Highly Enantioselective Hydrogenation Reactions," J. Am. Chem. Soc. 113 (22), 8518–8519 (1991).

15. S.J.C. Taylor et al., "Choice of Biocatalyst in the Development of Industrial Biotransformations," in Stereoselective Biocatalysis, R.N. Patel, Ed. (Marcel Dekker, New York, 2000), p. 397–413.

16. U. Berens, "Process for Preparing Cyclic Phosphines," US Patent 6545183, 1999.

17. U. Berens, M.J. Burk, and A. Gerlach, "Chiral 1,1-Diphosphetanylferrocenes: New Ligands for Asymmetric Catalytic Hydrogenation of Itaconate Derivatives," Angew. Chem. Int. Ed. 39 (11), 1981–1984 (2000).

18. M.Green, T.A. Kuc, and S.H.J. Taylor, J. Chem. Soc (D) Chem. Comm. (22), 1553–1554 (1970).

19. J.A. Ramsden and P.H. Moran, "Process for Preparting Catonic Rhodium Complexes," Patent WO 2005032712, Chem. Abstr. 142, 394141 (2005).

20. I. Appleby, I. et. al., "Efficient Synthesis of an Imidazole-Substituted δ-Amino Acid by the Integration of Chiral Technologies," Org. Lett. 7 (10), 1931–1934 (2005).

21. D. Chaplin et al., "Industrially Viable Syntheses of Highly Enantiomerically Enriched 1-Aryl Alcohols via Asymmetric Hydrogenation," Org. Process Res. Dev. 7 (1), 89–94 (2003).

22. H. Doucet, et al., "Trans-[RuCl2(phosphane)2(1,2-diamine)] and Chiral trans-[RuCl2 (diphosphane)(1,2-diamine)]: Shelf-Stable Precatalysts for the Rapid, Productive, and Stereoselective Hydrogenation of Ketones," Angew. Chem. Int. Ed. 37 (12), 1703–1707 (1998).

23. P.H.Moran, "Process for Making Diphosphine-Ruthenium Diamine Complexes," WO Patent 2007005550, Chem. Abstr. 146, 133961 (2007).

24. M.T. Reetz and X. Li, "An Efficient Catalyst System for the Asymmetric Transfer Hydrogenation of Ketones: Remarkably Broad Substrate Scope," J. Am. Chem. Soc. 128 (4), 1044–1045 (2006).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here